Immuron Letter to Shareholders: Projects Update
Provided By GlobeNewswire
Last update: May 30, 2025
Highlights:
MELBOURNE, Australia, May 30, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to provide shareholders with a brief update on progress with a number of projects.
Read more at globenewswire.com
